| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Secretary | Director
2 companies
Richard Ogawa is Secretary at PALX and has filed Form 4s across 2 companies. Richard Ogawa's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $26.4M at current prices.
The biggest single holding is PALX (~$26.4M) as Secretary. Net of sales, the PALX filings show accumulation of 12,500 shares.
Richard Ogawa has 16 Form 4 filings on record from September 2020 to July 2026, across 2 companies: Secretary at Palomino Laboratories (PALX), 2026; Director at Amesite (AMST), 2020–2024.
The 18 reported transactions were 14 option or other derivative awards, 3 open-market purchases and 1 other transaction.
Counted by filing, the open-market trades come to 3 purchases worth about $92K and no sales.
The largest open-market purchase was 12,500 shares of PALX at an average $4.00 on April 20, 2026, about $50K.